Clinical trial

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

NCT00392197

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-11-01

PhasePHASE4

Study timeline

Study start (unknown)2006-11-01Date precision: month

Registry last updated2014-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

AripiprazoleDRUG · verified · RxNorm: aripiprazole

Sponsors & collaborators

Otsuka Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00392197 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.